‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Keeping Current
SGLT2 Inhibitor Treatment for HFrEF: Demonstrating Safety Beyond the Heart
30
00:00:00
/ 00:33:58
30